Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.

Toumi M, Aballea S.

Open source

DOI
10.1080/20016689.2020.1758390
Published
2020-05-13
Container
J Mark Access Health Policy
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/20016689.2020.1758390,
  title = {Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.},
  author = {Toumi M and  Aballea S.},
  year = {2020},
  journal = {J Mark Access Health Policy},
  doi = {10.1080/20016689.2020.1758390},
  url = {https://doi.org/10.1080/20016689.2020.1758390}
}

RIS

TY  - JOUR
TI  - Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.
AU  - Toumi M
AU  -  Aballea S.
PY  - 2020
JO  - J Mark Access Health Policy
DO  - 10.1080/20016689.2020.1758390
UR  - https://doi.org/10.1080/20016689.2020.1758390
ER  - 

APA

M, T., & S., A. (2020). Commentary on "Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open label non-randomized clinical trial" by Gautret et al.. J Mark Access Health Policy. https://doi.org/10.1080/20016689.2020.1758390

Source records